Literature DB >> 16175472

Annual periodic increases in serum carcinoembryonic antigen concurrent with ground-glass opacity in the lung: report of a case.

Tsutomu Sakuma1, Yumiko Iwata, Yoshimichi Ueda, Xiu Gu, Makoto Sugita, Motoyasu Sagawa.   

Abstract

A 63-year-old woman underwent a video-assisted thoracoscopic lobectomy for cancer of the right lung in 1999. The following year, a lesion with ground-glass opacity was found in the left lung, and pathological examination after a partial lung resection revealed atypical adenomatous hyperplasia with expression of carcinoembryonic antigen (CEA). During postoperative screening tests for tumor recurrence, there were periodic increases in the serum CEA level by twofold above the normal levels in 2002 and 2003. Clinical evaluations, including laboratory tests, radiographic imaging, and endoscopy examinations, showed no evidence of a CEA-producing tumor, except for a new ground-glass opacity in the left lung. To our knowledge, this is the first report of periodic increases in serum CEA levels in a patient with ground-glass opacity in the lung, not reflecting recurrence of the lung tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175472     DOI: 10.1007/s00595-005-3010-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Detection apparatus for multiple heterogeneous chemiluminescence immunoassay configurations.

Authors:  O S Khalil; T F Zurek; C Pepe; K Genger; D G Huff; C Coleman; C Hanna; R Hu; J Mackowiack; L Bennett
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

2.  Focal ground-glass opacity detected by low-dose helical CT.

Authors:  Masao Nakata; Hideyuki Saeki; Ichiro Takata; Yoshihiko Segawa; Hiroshi Mogami; Koichi Mandai; Kenji Eguchi
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

3.  Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test.

Authors:  Gianfranco Buccheri; Domenico Ferrigno
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

Review 4.  Tumor markers: value and limitations in the management of cancer patients.

Authors:  S E Bates; D L Longo
Journal:  Cancer Treat Rev       Date:  1985-09       Impact factor: 12.111

5.  Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence.

Authors:  Tatsuya Yoshimasu; Yozo Kokawa; Shoji Oura; Issei Hirai; Rie Sasaki; Hirokazu Tanino; Teruhisa Sakurai; Yoshitaka Okamura
Journal:  Cancer Sci       Date:  2003-08       Impact factor: 6.716

6.  Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.

Authors:  M Diez; A Gomez; F Hernando; M D Ortega; M L Maestro; A Torres; J M Mugüerza; A Gutierrez; J Granell; J L Balibrea
Journal:  Int J Biol Markers       Date:  1995 Jan-Mar       Impact factor: 3.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.